Anal Cancer
161
31
47
70
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
29 trials with published results (18%)
Research Maturity
70 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
10.6%
17 terminated out of 161 trials
80.5%
-6.1% vs benchmark
7%
12 trials in Phase 3/4
41%
29 of 70 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 70 completed trials
Clinical Trials (161)
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment
DESTINY-PANTUMOUR04
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers
ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
Distance-Based Exercise to Preserve Function and Prevent Disability
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
Integrated Cancer Repository for Cancer Research
ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
COQ10 and Vitamin E for Off-Target Radiation Toxicity
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Individual Following in Anal Cancer With PET/CT
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Blood Biomarkers Based Screening for HPV-driven OPC
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
Self-sampling to Optimize Anal Lesion Outcomes
Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis